Table 2.
Characteristic | Hazard ratio | p-value |
Age: | < 0.001 | |
Young (≤ 49 years) | 1 | – |
Middle age (50–73 years) | 0.997 | 0.921 |
Elderly (≥ 74 years) | 1.195 | < 0.001 |
Sex: | 0.176 | |
Female | 1 | – |
Male | 1.031 | – |
Race: | < 0.001 | |
Black | 1 | – |
White | 0.999 | 0.973 |
Other | 0.921 | 0.044 |
Unknown | 0.428 | < 0.001 |
T stage: | < 0.001 | |
T0 | 1 | – |
T1 | 0.896 | 0.473 |
T2 | 0.672 | 0.012 |
T3 | 0.739 | 0.051 |
T4 | 0.923 | 0.603 |
TX | 0.881 | 0.403 |
N stage: | < 0.001 | |
N0 | 1 | – |
N1 | 1.054 | 0.046 |
N2 | 1.138 | 0.017 |
N3 | 1.311 | < 0.001 |
Unknown | 1.172 | < 0.001 |
Surgery: | < 0.001 | |
No | 1 | – |
Yes | 0.489 | – |
Lymph node: | 0.061 | |
Resection | 1 | – |
Biopsy | 1.197 | 0.098 |
None | 1.179 | 0.015 |
Unknown | 1.325 | 0.030 |
Chemotherapy: | < 0.001 | |
Yes | 1 | – |
No | 2.878 | – |
Radiotherapy: | 0.417 | |
Yes | 1 | – |
No | 1.192 | 0.186 |
Unknown | 1.009 | 0.778 |